- Original article
- Open access
- Published:
Assessment of immunoglobulin G antibodies against oxidized low-density lipoproteins in patients with acute coronary syndrome
The Egyptian Journal of Internal Medicine volume 25, pages 177–184 (2013)
Abstract
Background
Oxidative modification of low-density lipoproteins (LDLs) induces formation of immunogenic epitopes in the LDL molecule, which leads to the formation of antibodies against oxidized low-density lipoprotein (OxLDL) that can be detected in serum.
Aim of the study
The objective of this study was to evaluate the association between autoantibodies against OxLDL and acute coronary syndrome (ACS).
Patients and methods
A total of 50 patients diagnosed as having ACS (37 male patients and 13 female patients), age ranging between 19 and 82 years and admitted to the critical care department, Cairo University, and 19 matched healthy controls were enrolled in our study. All patients were subjected to detailed medical history-taking and physical examination, serial 12-lead ECGs, serial cardiac biomarkers on admission and 24 h later, echocardiography, coronary angiography and assessement of severity using the Gensini score, and IgG anti-OxLDL antibodies measurement.
Results
We found significant difference in the level of antibody between patients with ACS and matched healthy controls (P < 0.001). With respect to the correlation of anti-OxLDL antibodies and the severity of ACS, we found significant correlation between the level of antibodies in patients with ACS as assessed by the Gensini score (r = 0.709) as well as between the echocardiographic findings as assessed by the wall motion score index (r = 0.589). During hospitalization, there was significant correlation of the antibody level with mechanical complications (P = 0.047) and needed immediate intervention (P < 0.001). However, the antibody level was correlated with malignant arrhythmias but P value (0.219) was insignificant because of high SD, and there was no correlation with ischemic complications (P = 0.798).
Conclusion
With respect to the correlation of anti-OxLDL antibodies and ACS, the patients with ACS had higher anti-OxLDL antibodies level. In addition, anti-OxLDL antibodies level was correlated with the Gensini score, wall motion score index, and major adverse cardiovascular events during hospitalization.
References
Palinski W, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 1989; 86: 1372–1376.
Rossi GP, et al. Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients. Circulation 2003; 108: 2467–2472.
Fuster V, Lewis A Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2126–2146.
Laczik R, et al. Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome. Lupus 2011; 20: 730–735.
Inoue T, et al. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 2001; 37: 775–779.
Soltesz P, et al. Evaluation of antibodies to oxidized low–density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease. Thromb Haemost 2007; 98: 413–419.
Medeiros AM, et al. Antibodies against oxLDL and acute coronary syndrome. Arq Bras Cardiol 2010; 95: 47–54.
Puurunen M, et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 1994; 154: 2605–2609.
Dotevall A, et al. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women. Clin Sci (Lond) 2001; 101: 523–531.
Ma LQ, Zheng H, Wu SZ. Levels of C-reactive protein and antibodies against oxidized low-density lipoprotein in patients with different types of coronary heart disease. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 1068–1070.
Sherer Y, et al. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies. Cardiology 2001; 95: 20–24.
Greco TP, et al. Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndrome. Am J Clin Pathol 2009; 132: 613–620.
Tsai WC, et al. Relation between antibody against oxidized low-density lipoprotein and extent of coronary atherosclerosis. J Formos Med Assoc 2002; 101: 681–684.
Che J, et al. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score. Cardiol J 2011; 18: 364–370.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mokhtar, M.S., Hassan Zaghla, H.E., Samy, W. et al. Assessment of immunoglobulin G antibodies against oxidized low-density lipoproteins in patients with acute coronary syndrome. Egypt J Intern Med 25, 177–184 (2013). https://doi.org/10.4103/1110-7782.124976
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/1110-7782.124976